Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal cognitive outcomes in two progressive supranuclear palsy clinical trials.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Trajectories of brain structure and function in young adult carriers of genetic frontotemporal dementia variants.

medRxiv : the preprint server for health sciences·2026
Same author

Clinical Associations of Cerebrospinal Fluid TMEM106B in Familial and Sporadic Frontotemporal Dementia.

JAMA neurology·2026
Same author

Development and validation of a harmonized memory score for multicenter Alzheimer's disease and related dementia research.

Alzheimer's research & therapy·2026
Same author

The BEYONDD Pilot Study: A Decentralized Community-Engaged Research Framework for Multimodal Characterization of Neurodegenerative Risk in a Multi-Ethnic, Midlife Cohort with Subjective Cognitive or Behavioral Complaints.

medRxiv : the preprint server for health sciences·2026
Same author

Remote, self-administered, smartphone cognitive testing in a registry-based cohort: Feasibility, reliability, and validity findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Related Experiment Video

Updated: Mar 22, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.4K

Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain.

Philipp A Jaeger1,2,3, Kurt M Lucin4,5, Markus Britschgi4,6

  • 1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. pjaeger@ucsd.edu.

Molecular Neurodegeneration
|April 27, 2016
PubMed
Summary

Researchers discovered Growth-Differentiation Factor (GDF) signaling as a new pathway linked to Alzheimer's disease. Blood tests analyzing signaling proteins offer insights into early molecular changes, aiding Alzheimer's research.

More Related Videos

Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting
10:51

Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting

Published on: April 10, 2014

16.9K
Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue
11:49

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Published on: August 28, 2021

5.1K

Related Experiment Videos

Last Updated: Mar 22, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.4K
Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting
10:51

Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting

Published on: April 10, 2014

16.9K
Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue
11:49

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Published on: August 28, 2021

5.1K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Sporadic Alzheimer's disease (AD) biological pathways remain largely unknown.
  • Cognitive symptoms manifest decades after molecular onset, hindering early research.
  • Molecular research is often limited to late-stage post-mortem brain tissue studies.

Purpose of the Study:

  • To identify molecular pathways contributing to sporadic Alzheimer's disease.
  • To explore the link between cellular pathology and circulatory signaling proteins.
  • To develop novel diagnostic or therapeutic strategies for Alzheimer's disease.

Main Methods:

  • Probed relative levels of ~600 secreted signaling proteins in blood using antibody microarrays.
  • Mapped disease-specific molecular networks from protein data.
  • Utilized independent genome and transcriptome data to corroborate pathways.

Main Results:

  • Identified Growth-Differentiation Factor (GDF) signaling as a novel Alzheimer's disease-relevant pathway.
  • Confirmed the link between cellular pathology and circulatory signaling proteins through in vivo and in vitro experiments.
  • Demonstrated the informative nature of secreted signaling molecules in blood for Alzheimer's research.

Conclusions:

  • Growth-Differentiation Factor (GDF) signaling represents a significant, previously unrecognized pathway in Alzheimer's disease.
  • Circulatory signaling proteins provide accessible information about early, otherwise unobservable, molecular pathology.
  • This study opens new avenues for early Alzheimer's detection and intervention.